Tracheal collapse: clinical trial in dogs (CasMin Twine)

PlayPLAY VIDEO

Minimum 3.666 euros
 
 
 
670 out of 18.330 eurosRemaining 66 days

I want to donate

50 €
250 €
500 €
FacebookTwitterWhatsappMail

Rewards

Support 50 €

€ 50 Personalized appreciation and delivery of an extended topic on tracheal collapse.

Support 250 €

€ 250 Personalized thanks and delivery of the book "Interventional Radiology, half a century innovating in medicine".

Support 500 €

€ 500 Personalized gratitude and face-to-face assistance to a surgery to place the new prosthesis (depending on your possibility or video of it).

It is a chronic and progressive disease of the trachea and lower respiratory tract, without effective treatment

The project
Who is behind

What is our goal?

Tracheal stenosis (tracheal collapse) is a pathology whose medical alternative consists on the placement of intra-tracheal prostheses that keep its lumen open. These prostheses can be metallic or plastic.

One of the causes of tracheal stenosis is tracheomalacia. It is characterized by a soft tracheal cartilage, which prevents it from being a "rigid tube" and as result it becomes a flaccid structure unable to remain open during the respiratory cycle.

In the case of humans, it is a congenital abnormality that mainly affects children. While patient´s grow, the cartilage acquires its normal consistency, but in the meantime, it is necessary to keep an open growing trachea. For this reason, it is necessary to place plastic prostheses of different sizes that adapt it to the rapid growth of the patient. To achieve this objective, the use of plastic prostheses is necessary. However, they present numerous complications, such as: migration, mucous accumulation, infection, and/or reduction of the tracheal lumen.

In the case of animals, dogs are the most affected, but unlike in humans, it is a frequent disease observed in older animals and it is a degenerative process that worsens over time. The alternative treatment involves aggressive open surgery, in which extratracheal rings are placed. It provides support from outside the trachea. Alternatively, the implantation of a metallic stent inside it.

In these cases, the implantation of these prostheses is a quick procedure with fewer possibilities of short-term complications compared to open surgery. However, in the medium and long term, complications such as migration, stent fracture, accumulation of mucus, infection or intraluminal tissue overgrowth may occur due to the reaction of a foreign body. All these complications are difficult to solve since these stents are not removable. Once implanted, they remain embedded in the tracheal wall and cannot be removed.

CasMin Twine is a new prosthesis that, given its helical design, allows a new way of placement. The prosthesis is fixed to the trachea, completely avoiding migration and, it is removable with a lower risk of breakage and, consequently, the appearance of intraluminal overgrowth. Its simple morphology adapts to the anatomy of the trachea, moving with it in respiratory cycles and reducing the amount of metal in contact with the tissue.

In the first stage, prototypes were made in steel and satisfactory results were obtained after 12 months. Efficacy, tissue compatibility, ease of handling, and reproducibility were tested. After this, a clinical study was started in pathological canine patients. The prototypes of the prosthesis are made of nitinol, a biocompatible, superelastic and shape memory material, which provides it with suitable characteristics for its application.

The clinical study began about a year ago and, so far, 7 canine patients have been recruited, with a maximum follow-up of 11 months.

The current results are being promising, so it is considered that expanding the study to increase the number of patients and their follow-up would allow more reliable results.

Who will benefit from our project?

Because this pathology is naturally present in veterinary medicine, and it is considered similar to human one, clinical studies are performed on canine species. Therefore, the main beneficiary of this study are dogs suffering from tracheal collapse, it should be taken into account that this is the preliminary phase for its consideration in human medicine. So it will benefit children with tracheomalacia in an "indirect" way.

What will you achieve with your donation?

The study intends to continue for a further 18 months, during which more patients will be recruited (the first 6 months) and their follow-up will be completed for a minimum of 12 months.

The desired objective would be recruiting 15 more patients, to gain more experience, and to be able to transfer the results to human medicine. Taking advantage of this prosthesis and procedure, the two fields simultaneously, veterinary medicine and pediatric medicine.

The cost of each patient is € 1222, so with the minimum amount, 3 patients could be assumed, and, with the optimal objective, 15 patients.

The amount obtained will determine the number of patients to be included in the clinical trial. The greater the number of patients, the more reliable the results will be.

Do you want more information?

If you want to know more about us, the team behind us, the investigations and lines in which we work, all the information is available on our website www.gitmi.es.

Abaout Precipita
About us
FAQs
Contact
Find us
C/Pintor Murillo, 15
28100 Alcobendas (Madrid) - España
T.+(00 34) 91 425 09 09
AENOR
A project from :Logo MinisterioLogo Fecyt
FECYT 2020. All right reserved
Legal terms | Privacy policy | Cookies policy
Powered by StockCrowd  Powered by StockCrowd
Cookies
Información que debes conocer
Este sitio web utiliza cookies, para conocer nuestra política de cookies haga click aquí. Si estás de acuerdo con nuestra política de cookies haga click en el botón continuar.